These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6736661)

  • 21. Human, rat or mouse hybridomas secrete high levels of monoclonal antibodies following transplantation into mice with severe combined immunodeficiency disease (SCID).
    Ware CF; Donato NJ; Dorshkind K
    J Immunol Methods; 1985 Dec; 85(2):353-61. PubMed ID: 4078317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of ascites production for monoclonal antibodies in BALB/c and BALB/c-derived cross-bred mice.
    Stewart F; Callander A; Garwes DJ
    J Immunol Methods; 1989 May; 119(2):269-75. PubMed ID: 2542413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production and characterization of monoclonal antibodies against tissue-type plasminogen activator.
    Ding H; Wang JY; Song HY
    Chin J Biotechnol; 1990; 6(3):223-7. PubMed ID: 2129498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of immunosuppressants and antibiotics on human monoclonal antibody production in SCID mouse ascites by five heterohybridomas.
    Yoshinari K; Arai K
    Hybridoma; 1998 Feb; 17(1):41-5. PubMed ID: 9523236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of severe combined immunodeficient (SCID) mice to produce human hybridoma ascites.
    McKnight ME; Prather K; Koda K; DeBoer KF; Glassy MC
    Hum Antibodies Hybridomas; 1991 Oct; 2(4):190-3. PubMed ID: 1751782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production in ascites fluid of biosynthetically labelled monoclonal antibody to Theileria parva sporozoites.
    Dobbelaere DA; Spooner PR
    J Immunol Methods; 1985 Oct; 82(2):209-14. PubMed ID: 3930611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on monoclonal antibody against recombinant human granulocyte colony-stimulating factor.
    Guo X; Wang A; Li X; Guo Z; Zhang Y
    Chin Med Sci J; 1991 Dec; 6(4):212-6. PubMed ID: 1725968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Conditions for forming ascitic tumors in hybridoma cultivation in vivo].
    Novokhatskiĭ AS; Malakhova IV; Gaĭdamovich SIa; Mel'nikova EE; Sveshnikova NA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):13-7. PubMed ID: 3751404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modifications of hybridoma technology which improve the yield of monoclonal antibody producing cells.
    Orlik O; Altaner C
    J Immunol Methods; 1988 Nov; 115(1):55-9. PubMed ID: 2848072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of hollow fiber bioreactors as an alternative to murine ascites production for small scale monoclonal antibody production.
    Jackson LR; Trudel LJ; Fox JG; Lipman NS
    J Immunol Methods; 1996 Feb; 189(2):217-31. PubMed ID: 8613673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rat monoclonal antibodies. VII. Enhancement of ascites production and yield of monoclonal antibodies in rats following pretreatment with pristane and Freund's adjuvant.
    Kints JP; Manouvriez P; Bazin H
    J Immunol Methods; 1989 May; 119(2):241-5. PubMed ID: 2723442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane.
    Satoh M; Reeves WH
    J Exp Med; 1994 Dec; 180(6):2341-6. PubMed ID: 7964507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dialysis-based bioreactor systems for the production of monoclonal antibodies--alternatives to ascites production in mice.
    Bruce MP; Boyd V; Duch C; White JR
    J Immunol Methods; 2002 Jun; 264(1-2):59-68. PubMed ID: 12191510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production and characterization of monoclonal antibodies against human IgG in Balb/c mouse.
    Majidi J; Baradaran B; Hassan ZM; Mostafaie A
    Hum Antibodies; 2005; 14(1-2):1-5. PubMed ID: 16424594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation and identification of anti-fumonisin B1 monoclonal antibody].
    Guo Y; Liu X; Liu J
    Wei Sheng Yan Jiu; 1999 Sep; 28(5):297-9. PubMed ID: 12712702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of anticancer human monoclonal antibody--establishment of human monoclonal antibody to gastric cancer by human-mouse hybridoma].
    Liu H
    Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):242-4. PubMed ID: 3248478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific immunoglobulin production and enhanced tumorigenicity following ascites growth of human hybridomas.
    Kozbor D; Abramow-Newerly W; Tripputi P; Cole SP; Weibel J; Roder JC; Croce CM
    J Immunol Methods; 1985 Jul; 81(1):31-42. PubMed ID: 4020147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some ascites monoclonal antibody preparations contain contaminants that bind to selected Golgi zones or mast cells.
    Spicer SS; Spivey MA; Ito M; Schulte BA
    J Histochem Cytochem; 1994 Feb; 42(2):213-21. PubMed ID: 7507139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and characterization of monoclonal antibodies against 17alpha-hydroxyprogesterone.
    Chong H; Cheah SH; Ragavan M; Johgalingam VT
    Hybridoma (Larchmt); 2006 Feb; 25(1):34-40. PubMed ID: 16475880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.